Significant increase (p<0.001) in the levels of glucose, uric acid, Creatinine, inorganic phosphorous levels were observed with 100, 200, 300µg of CP treatment, where as CP, 200µg caused no significant increase in urea which showed an increased trend (p<0.001) with 300µg compared with control. Protein levels were significantly increased with 100 µg (p<0.05) and with 200 µg and 300 µg (p<0.001) of CP treatment. Ascorbic acid, calcium and cholesterol levels were significantly decreased (p<0.00) in a dose dependant manner with CP treatment in AF. Whereas with CP + AP treatment a significant decrease (p<0.001) in glucose, protein, urea, uric acid, Creatinine and inorganic phosphorous were observed. Glucose levels were significantly decreased (p<0.05) with 6.0mg AP treatment. Ascorbic acid levels were significantly decreased (p<0.001) with CP treatment. Whereas CP+AP caused significant (p<0.001) increase in ascorbic acid levels. The calcium levels were significantly decreased (p<0.001) with CP treatment. The cholesterol, sodium and potassium significantly decreased with CP treatment, whereas increased AP treated embryos. The enzymatic activity of alkaline Phosphatase (ALP), serum Alanine aminotransferase (ALT) and serum aspartate aminotransferase (AST) were increased considerably (p<0.001) with CP treatment in AF compared with to controls, whereas decreased with CP + AP treatment. The ionic balance was significantly decreased with CP treatment compared with to controls. Table 3.2 shows the effect of CP biochemical parameters in chick embryonic liver. Liver protein, inorganic phosphorous and ascorbic acid levels were found to significant decrease (p<0.001) with CP treatment. Increased activity of ALP, ALT, AST, LDH and MDH
Significant increase (p<0.001) in the levels of glucose, uric acid, Creatinine, inorganic phosphorous levels were observed with 100, 200, 300µg of CP treatment, where as CP, 200µg caused no significant increase in urea which showed an increased trend (p<0.001) with 300µg compared with control. Protein levels were significantly increased with 100 µg (p<0.05) and with 200 µg and 300 µg (p<0.001) of CP treatment. Ascorbic acid, calcium and cholesterol levels were significantly decreased (p<0.00) in a dose dependant manner with CP treatment in AF. Whereas with CP + AP treatment a significant decrease (p<0.001) in glucose, protein, urea, uric acid, Creatinine and inorganic phosphorous were observed. Glucose levels were significantly decreased (p<0.05) with 6.0mg AP treatment. Ascorbic acid levels were significantly decreased (p<0.001) with CP treatment. Whereas CP+AP caused significant (p<0.001) increase in ascorbic acid levels. The calcium levels were significantly decreased (p<0.001) with CP treatment. The cholesterol, sodium and potassium significantly decreased with CP treatment, whereas increased AP treated embryos. The enzymatic activity of alkaline Phosphatase (ALP), serum Alanine aminotransferase (ALT) and serum aspartate aminotransferase (AST) were increased considerably (p<0.001) with CP treatment in AF compared with to controls, whereas decreased with CP + AP treatment. The ionic balance was significantly decreased with CP treatment compared with to controls. Table 3.2 shows the effect of CP biochemical parameters in chick embryonic liver. Liver protein, inorganic phosphorous and ascorbic acid levels were found to significant decrease (p<0.001) with CP treatment. Increased activity of ALP, ALT, AST, LDH and MDH
UGCMRPFINALREPORTPEAPCODCE.docx